The FDA has issued an alert for healthcare providers to quarantine any sterile products distributed from NuVision Pharmacy of Dallas and not administer them to patients, according to the American Society of Anesthesiologists.
Investigators recently inspected the company's facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
Study: Anesthesia Not Linked to Dementia, Alzheimer's in Elderly Patients
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
FDA Officially Lowers Dose Recommendation for Zolpidem Sleep Drug
Investigators recently inspected the company's facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
Study: Anesthesia Not Linked to Dementia, Alzheimer's in Elderly Patients
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
FDA Officially Lowers Dose Recommendation for Zolpidem Sleep Drug